Eli Lilly and Company

Senior Advisor - Real World Analytics

Indianapolis, Indiana, United States

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, PharmaceuticalsIndustries

Requirements

Candidates should possess a Bachelor’s degree in Statistics, Biostatistics, Epidemiology, or a related scientific field, and hold a Master’s degree or equivalent experience. Strong statistical modeling and analysis skills are required, along with experience in real-world data analysis, including claim data, registry data, and electronic medical records (EMR). Demonstrated expertise in designing and executing non-interventional studies and Real-World Evidence (RWE) research is essential, as is a solid understanding of Health Technology Assessment (HTA) and reimbursement processes globally. Experience with causal inference methods and network meta-analyses is preferred.

Responsibilities

The Senior Advisor for Real-World Analytics will provide technical leadership and expertise in initiating and carrying out evidence generation plans for Medical Affairs, Access & Reimbursement, and Real-World Evidence. They will lead statistical design and analysis, including developing protocols, analysis plans, and executing statistical activities for non-interventional studies and RWE research. The role involves working with scientists to ensure scientifically sound evidence generation, justifying methodology selected, and leading statistical activities to answer efficacy and safety questions. Furthermore, the Senior Advisor will provide technical statistical leadership for data-related research in HTA and reimbursement globally, perform peer review of work products, oversee CRO suppliers, and communicate study results through various channels, including reimbursement dossiers, manuscripts, and presentations. They will also maintain up-to-date knowledge of statistical methodology, particularly in real-world data analysis, and collaborate with team members and external partners to communicate results effectively, understanding disease states and the competitive landscape to enhance customer focus and collaboration.

Skills

Statistical Design
Statistical Analysis
Evidence Generation
Real-World Evidence
Data Analysis
Problem Solving
Scientific Soundness

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI